Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Real Time & Level II Data
Showcase Companies
DealRoom
News Focus
ApartmentLove (C.APLV) Announces Agreement with Yardi (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Knight Therapeutics Inc
T.GUD
Alternate Symbol(s):
KHTRF
Healthcare
Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company is engaged in the development, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It also finances other life sciences companies, invests in venture capital funds and develops pharmaceutical...
products, including those to treat neglected tropical and rare pediatric diseases. The Company’s products include EXELON, BIJUVA, IMVEXXY, IBSRELA, TRELSTAR Prostate, TRELSTAR Endometriosis, Nerlynx, Nerlynx Patient Checklist, Nerlynx Prescriber Checklist, Burinex, Probuphine, Movantik and Neuragen. It owns Biotoscana Investments S.A., a pan-Latin American specialty pharmaceutical company. The Company’s subsidiary includes Knight Therapeutics International S.A., which develops pharmaceuticals, including those used to treat neglected tropical diseases and rare pediatric diseases.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:GUD)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(115)
•••
longrun86
X
Comment by
longrun86
on Sep 27, 2023 1:00pm
RE:RE:Goodman and Armoyan Buying
I think Armoyan is probably thinking the same things we are. There is a lot of capital to deploy in the future There are challenges with operating margins that need to be addressed
...more
(21)
•••
EbbFlow88
X
Comment by
EbbFlow88
on Sep 27, 2023 12:22pm
RE:Goodman and Armoyan Buying
It's nice to finally see Goodman buy more in the open market. It will be interesting to see how Armoyan's partnership will unfold with Knight. He originally mentioned he will be passive
...more
(0)
•••
ShiningArmour
X
Post by
ShiningArmour
on Sep 26, 2023 4:51pm
Goodman and Armoyan Buying
More insider buys. Armoyan and Jonathan buying more shares in the public market. This is a good sign for things to come
•••
Jon Brown
X
Post by
Jon Brown
on Sep 26, 2023 4:22pm
@ the Bell: TSX joins North American markets in the red
Canada’s main stock index closed lower on Tuesday, as U.S. Treasury yields reached multi-year highs on bets interest rates stay elevated.
read article.
(17)
•••
Stockoman1
X
Comment by
Stockoman1
on Sep 26, 2023 10:10am
RE:Shorts
There is a signifigant increase in short positions in numerous TSX listed stocks the last month or so. This includes blue chips like TD bank, RBCm BNS Enbridge, Rogers and so on. https
...more
•••
Jon Brown
X
Post by
Jon Brown
on Sep 25, 2023 4:14pm
@ the Bell: TSX tries to avoid five-day losing streak
The TSX extended or broke its losing steak to five days, weighed down by material stocks as metals prices struggled against a stronger dollar
read article.
(5)
•••
wofats
X
Post by
wofats
on Sep 23, 2023 1:14pm
Shorts
A large increase in the last 30 days . $GUD.TO KNIGHT THERAPEUTICS INC. 3,571,557 1,138,889 14 Sep 2023 $GUD.TO KNIGHT
...more
•••
Jon Brown
X
Post by
Jon Brown
on Sep 21, 2023 9:00am
Buzz on the Bullboards: Cooler days means hotter markets
Fall officially starts this weekend and with it comes the annual rush of business activity, you need look no further than our own Bullboards.
read article.
Thematica Insights Report and Investor Guide
Thematica: Battery Metals Report
Download our Investor’s Guide and learn how/why Battery Metals are playing a vital role in the EV Revolution.
Jeff Nielson
22 September 2023 09:28
(6)
•••
curiousj
X
Comment by
curiousj
on Sep 12, 2023 4:11pm
RE:RE:RE:Interesting Stats
a major part of COGS would be related to royalties, so upfront investments for new drug intangible to replace legacy ones would be minor relative to the royalties of 15-20%+. and also remember many
...more
(21)
•••
EbbFlow88
X
Comment by
EbbFlow88
on Sep 12, 2023 12:28pm
RE:RE:Interesting Stats
An example in 2022 annual report: On the Income Statement, it reads "Amortization of Intangible Assets" = $51.7M Under Operating Cash Flow, it reads "Depcreciation & Amortization
...more
(21)
•••
EbbFlow88
X
Comment by
EbbFlow88
on Sep 12, 2023 12:04pm
RE:RE:Interesting Stats
So you're saying that the D&A is coming from hard assets from GBT? What about the drug deals that are being depreciated over their "useful" life and that will have to be replenished
...more
(6)
•••
curiousj
X
Comment by
curiousj
on Sep 12, 2023 11:54am
RE:Interesting Stats
OCF is the most important metric for GUD. D&A is almost entirely from GBT, and so very will little goodwill. you're expensing a large part of the terminal value paid for GBT, so you save taxes
...more
(21)
•••
EbbFlow88
X
Post by
EbbFlow88
on Sep 12, 2023 11:23am
Interesting Stats
I pulled some data from the past number of annual reports. The book value has been dropping each year which is obviously not a good thing. However, the shares outstanding have been decreasing more
...more
(5)
•••
wofats
X
Post by
wofats
on Sep 12, 2023 10:49am
Someone sees value
Filed 2023-09-1118:45 Tx date 2023-09-08 $GUD Knight Therapeutics Inc. Armoyan, Sime 3 - 10% Security Holder of Issuer
...more
(15)
•••
GoldenInvestor
X
Post by
GoldenInvestor
on Sep 08, 2023 2:57pm
More focus coming to biotech & micro biotech
Being discussed on cnbc.
(21)
•••
EbbFlow88
X
Comment by
EbbFlow88
on Sep 08, 2023 11:33am
RE:RE:RE:Adjusted enterprise value = Exelon
Nice catch on this btw. Someone from Desjardins and CIBC outside of Knights buybacks have been loading up. Hard to tell if CIBC is the same person but Desjardins likely is.
(15)
•••
GoldenInvestor
X
Post by
GoldenInvestor
on Sep 08, 2023 9:32am
Question regarding revenue growth compared to Paladin
Question to the board.. How is Knight executing on its revenue growth, sales growth, & other metrics. compared to its predecessor company at similar stages of growth? is it on the same
...more
(21)
•••
EbbFlow88
X
Comment by
EbbFlow88
on Sep 08, 2023 8:34am
RE:RE:RE:Adjusted enterprise value = Exelon
I agree regarding going private. I don't think they will for the reasons you gave but also because I don't think they would do that to their shareholders. Just making a point of how cheap the
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Electric Dreams: Transforming the World with a Clean Energy Future - Download Free Report Now!
Metallurgical Test Program at Los Cuyes Yielded Excellent Gold Recoveries
NorthStar Gaming inks $10 million deal with Playtech to expand into the rest of Canada
Discover Lithium Recycling at the Epicentre of the Largest EV Build Out in US History
Total revenue Increased 47% with Two +28% Dividend Increases in 6 Months – Learn More Here
Copper Exploration Company is on the Edge of a Big Discovery
Private Placement: Ready for a Golden Opportunity in Ghana and Canada?
Advanced Project Opportunities Throughout Argentina’s Lithium Triangle